The Stroke Rehabilitation Paradigm

Physical Medicine and Rehabilitation Clinics of North America

Volumn 18, Issue 4, 2007, Pages 631-650

  Kelly, Brian M ^a   Pangilinan Jr , Percival H ^a   Rodriguez, Gianna M ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; AMANTADINE; AMPHETAMINE; BASIC FIBROBLAST GROWTH FACTOR; BROMOCRIPTINE; CHOLINESTERASE INHIBITOR; CLOPIDOGREL; LEVODOPA; METHYLPHENIDATE; MODAFINIL; NEUROLEPTIC AGENT; NORADRENALIN; SEROTONIN UPTAKE INHIBITOR; TICLOPIDINE;

ALTERNATIVE MEDICINE; BRAIN DEPTH STIMULATION; CAROTID ENDARTERECTOMY; DIARRHEA; DISABILITY; ELECTROSTIMULATION; FITNESS; FUNCTIONAL ASSESSMENT; HIGH RISK POPULATION; HUMAN; LOW DRUG DOSE; MOTOR DYSFUNCTION; MOTOR PERFORMANCE; MUSCLE STRENGTH; NEUTROPENIA; PHYSICAL ACTIVITY; PRIORITY JOURNAL; REVIEW; RISK FACTOR; ROBOTICS; STROKE;

ACTIVITIES OF DAILY LIVING; ELECTRIC STIMULATION THERAPY; EXERCISE THERAPY; FEMALE; HUMANS; MALE; PHYSICAL THERAPY MODALITIES; RISK FACTORS; STROKE;

EID: 35548937335     PISSN: 10479651     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pmr.2007.07.006     Document Type: Review

References (139)

1. Heart and Stroke Statistical Update. Heart and Stroke Statistical Update. 2007.
2. Mannami T., Baba S., and Ogata J. Strong and significant relationships between aggregation of major coronary risk factors and the acceleration of carotid atherosclerosis in the general population of a Japanese city: the Suita study. Arch Intern Med 160 15 (2000) 2297-2303
3. Wolf P.A., Abbott R.D., and Kannel W.B. Atrial fibrillation as an independent risk factor for stroke: the Framingham study. Stroke 22 8 (1991) 983-988
4. Seshadri S., Beiser A., Kelly-Hayes M., et al. The lifetime risk of stroke: estimates from the Framingham study. Stroke 37 2 (2006) 345-350
5. Sacco R.L., Adams R., Albers G., et al. Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: a statement for healthcare professionals from the American Heart Association/American Stroke Association Council on stroke. Co-sponsored by the Council on Cardiovascular Radiology and Intervention: the American Academy of Neurology affirms the value of this guideline. Stroke 37 2 (2006) 577-617
6. Chobanian A.V., Bakris G.L., Black H.R., et al. The seventh report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. JAMA 289 19 (2003) 2560-2572
7. Rothwell P.M., Howard S.C., and Spence J.D. Relationship between blood pressure and stroke risk in patients with symptomatic carotid occlusive disease. Stroke 34 11 (2003) 2583-2590
8. Wolf P.A., D'Agostino R.B., Kannel W.B., et al. Cigarette smoking as a risk factor for stroke: the Framingham study. JAMA 259 7 (1988) 1025-1029
9. Kawachi I., Colditz G.A., Stampfer M.J., et al. Smoking cessation and decreased risk of stroke in women. JAMA 269 2 (1993) 232-236
10. Wannamethee S.G., Shaper A.G., Whincup P.H., et al. Smoking cessation and the risk of stroke in middle-aged men. JAMA 274 2 (1995) 155-160
11. Piechowski-Jozwiak B., and Bogousslavsky J. Cholesterol as a risk factor for stroke: the fugitive?. Stroke 35 6 (2004) 1523-1524
12. Donnan G.A., and Davis S.M. Stroke and cholesterol: weakness of risk versus strength of therapy. Stroke 35 6 (2004) 1526-1530
13. Grundy S.M., Cleeman J.I., Merz C.N., et al. Implications of recent clinical trials for the national cholesterol education program adult treatment panel III guidelines. Circulation 110 2 (2004) 227-239
14. Corvol J.C., Bouzamondo A., Sirol M., et al. Differential effects of lipid-lowering therapies on stroke prevention: a meta-analysis of randomized trials. Arch Intern Med 163 6 (2003) 669-676
15. Bucher H.C., Griffith L.E., and Guyatt G.H. Effect of HMGcoA reductase inhibitors on stroke: a meta-analysis of randomized, controlled trials. Ann Intern Med 128 2 (1998) 89-95
16. Eikelboom J.W., Hankey G.J., Anand S.S., et al. Association between high homocyst(e)ine and ischemic stroke due to large- and small-artery disease but not other etiologic subtypes of ischemic stroke. Stroke 31 5 (2000) 1069-1075
17. Iso H., Moriyama Y., Sato S., et al. Serum total homocysteine concentrations and risk of stroke and its subtypes in Japanese. Circulation 109 22 (2004) 2766-2772
18. Sacco R.L., Anand K., Lee H.S., et al. Homocysteine and the risk of ischemic stroke in a triethnic cohort: the NOrthern MAnhattan study. Stroke 35 10 (2004) 2263-2269
19. Mauriello A., Sangiorgi G., Palmieri G., et al. Hyperfibrinogenemia is associated with specific histocytological composition and complications of atherosclerotic carotid plaques in patients affected by transient ischemic attacks. Circulation 101 7 (2000) 744-750
20. Sacco R.L. Risk factors and outcomes for ischemic stroke. Neurology 45 2 Suppl 1 (1995) S10-S14
21. Viitanen M., Eriksson S., and Asplund K. Risk of recurrent stroke, myocardial infarction and epilepsy during long-term follow-up after stroke. Eur Neurol 28 4 (1988) 227-231
22. Johnson E.S., Lanes S.F., Wentworth III C.E., et al. A metaregression analysis of the dose-response effect of aspirin on stroke. Arch Intern Med 159 11 (1999) 1248-1253
23. Hirsh J., Dalen J.E., Fuster V., et al. Aspirin and other platelet-active drugs: the relationship among dose, effectiveness, and side effects. Chest 108 Suppl 4 (1995) 247S-257S
24. Hass W.K., Easton J.D., Adams Jr. H.P., et al. A randomized trial comparing ticlopidine hydrochloride with aspirin for the prevention of stroke in high-risk patients: ticlopidine aspirin stroke study group. N Engl J Med 321 8 (1989) 501-507
25. Committee C.S. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet 348 9038 (1996) 1329-1339
26. Diener H.C., Cunha L., Forbes C., et al. European stroke prevention study. 2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke. J Neurol Sci 143 1-2 (1996) 1-13
27. Sacco R.L., Sivenius J., and Diener H.C. Efficacy of aspirin plus extended-release dipyridamole in preventing recurrent stroke in high-risk populations. Arch Neurol 62 3 (2005) 403-408
28. Easton J.D. Dipyridamole plus aspirin for stroke prevention. Lancet Neurol 5 7 (2006) 553-554
29. Norrving B. Dipyridamole with aspirin for secondary stroke prevention. Lancet 367 9523 (2006) 1638-1639
30. North American Symptomatic Carotid Endarterectomy Trial Collaborators. Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. N Engl J Med 325 7 (1991) 445-453
31. Barnett H.J., and Haines S.J. Carotid endarterectomy for asymptomatic carotid stenosis. N Engl J Med 328 4 (1993) 276-279
32. Hobson R.W., Weiss D.G., Fields W.S., et al. Efficacy of carotid endarterectomy for asymptomatic carotid stenosis. N Engl J Med 328 4 (1993) 221-227
33. Kittner S.J., Stern B.J., Feeser B.R., et al. Pregnancy and the risk of stroke. N Engl J Med 335 11 (1996) 768-774
34. Wassertheil-Smoller S., Hendrix S., Limacher M., et al. Effect of estrogen plus progestin on stroke in postmenopausal women: the women's health initiative. A randomized trial. JAMA 289 20 (2003) 2673-2684
35. Writing Group for the Women's Health Initiative I. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the women's health initiative randomized controlled trial. JAMA 288 3 (2002) 321-333
36. Lee I.M., and Paffenbarger Jr. R.S. Physical activity and stroke incidence: the Harvard alumni health study. Stroke 29 10 (1998) 2049-2054
37. Sacco R.L., Gan R., Boden-Albala B., et al. Leisure-time physical activity and ischemic stroke risk: the Northern Manhattan stroke study. Stroke 29 2 (1998) 380-387
38. Twitchell T.E. The restoration of motor function following hemiplegia in man. Brain 74 4 (1951) 443-480
39. Kawamata T., Dietrich W.D., Schallert T., et al. Intracisternal basic fibroblast growth factor enhances functional recovery and up-regulates the expression of a molecular marker of neuronal sprouting following focal cerebral infarction. Proc Natl Acad Sci U S A 94 15 (1997) 8179-8184
40. Cao Y., D'Olhaberriague L., Vikingstad E.M., et al. Pilot study of functional MRI to assess cerebral activation of motor function after poststroke hemiparesis. Stroke 29 1 (1998) 112-122
41. Karni A., Meyer G., Rey-Hipolito C., et al. The acquisition of skilled motor performance: fast and slow experience-driven changes in primary motor cortex. Proc Natl Acad Sci U S A 95 3 (1998) 861-868
42. Ward N.S., Brown M.M., Thompson A.J., et al. Neural correlates of motor recovery after stroke: a longitudinal fMRI study. Brain 126 11 (2003) 2476-2496
43. Ward N.S., Brown M.M., Thompson A.J., et al. The influence of time after stroke on brain activations during a motor task. Ann Neurol 55 6 (2004) 829-834
44. Kelly C., Foxe J.J., and Garavan H. Patterns of normal human brain plasticity after practice and their implications for neurorehabilitation. Arch Phys Med Rehabil 87 Suppl 12 (2006) 20-29
45. Calautti C., and Baron J.C. Functional neuroimaging studies of motor recovery after stroke in adults: a review. Stroke 34 6 (2003) 1553-1566
46. Bobath B. Adult hemiplegia: evaluation and treatment (1968), Spottiswood, Ballintype, London
47. Knott M., and Voss D. Proprioceptive neuromuscular facilitation: patterns and techniques. 2nd edition (1968), Harper and Row, Hagerstown (MD)
48. Sawner K.A., and LaVigne J.M. Brunnstrom's movement therapy in hemiplegia: a neurophysiological approach. 2nd edition (1992), J.B. Lippincott, Philadelphia
49. Moreland J., and Thomson M.A. Efficacy of electromyographic biofeedback compared with conventional physical therapy for upper-extremity function in patients following stroke: a research overview and meta-analysis. Phys Ther 74 6 (1994) 534-543
50. Dickstein R., Hocherman S., Pillar T., et al. Stroke rehabilitation: three exercise therapy approaches. Phys Ther 66 8 (1986) 1233-1238
51. Basmajian J.V., Gowland C.A., Finlayson M.A., et al. Stroke treatment: comparison of integrated behavioral-physical therapy vs traditional physical therapy programs. Arch Phys Med Rehabil 68 5 Pt 1 (1987) 267-272
52. Schmidt RA. Motor learning principles for physical therapy. Contemporary Management of Motor Control Problems: Proceedings of the II STEP Conference. Alexandria VA Foundation for Physical Therapy; 1991. p. 49-63.
53. Visintin M., Barbeau H., Korner-Bitensky N., et al. A new approach to retrain gait in stroke patients through body weight support and treadmill stimulation. Stroke 29 6 (1998) 1122-1128
54. Humm J.L., Kozlowski D.A., James D.C., et al. Use-dependent exacerbation of brain damage occurs during an early post-lesion vulnerable period. Brain Res 783 2 (1998) 286-292
55. Hesse S., Schmidt H., Werner C., et al. Upper and lower extremity robotic devices for rehabilitation and for studying motor control. Curr Opin Neurol 16 6 (2003) 705-710
56. Parry R.H., Lincoln N.B., and Vass C.D. Effect of severity of arm impairment on response to additional physiotherapy early after stroke. Clin Rehabil 13 3 (1999) 187-198
57. Taub E., Miller N.E., Novack T.A., et al. Technique to improve chronic motor deficit after stroke. Arch Phys Med Rehabil 74 4 (1993) 347-354
58. Dromerick A., Lum P., and Hidler J. Activity-based therapies. NeuroRx 3 4 (2006) 428-438
59. Jette D.U., Warren R.L., and Wirtalla C. The relation between therapy intensity and outcomes of rehabilitation in skilled nursing facilities. Arch Phys Med Rehabil 86 3 (2005) 373-379
60. Kwakkel G., Wagenaar R.C., Koelman T.W., et al. Effects of intensity of rehabilitation after stroke: a research synthesis. Stroke 28 8 (1997) 1550-1556
61. Bode R.K., Heinemann A.W., Semik P., et al. Relative importance of rehabilitation therapy characteristics on functional outcomes for persons with stroke. Stroke 35 11 (2004) 2537-2542
62. Chen J., and Chopp M. Neurorestorative treatment of stroke: cell and pharmacological approaches. NeuroRx 3 4 (2006) 466-473
63. Weiss A., Suzuki T., Bean J., et al. High intensity strength training improves strength and functional performance after stroke. Am J Phys Med Rehabil 79 4 (2000) 369-376
64. Lindeman E., Spaans F., Reulen J., et al. Effects on force and surface EMG. J Electromyogr Kinesiol 9 6 (1999) 379-384
65. Ouellette M.M., LeBrasseur N.K., Bean J.F., et al. High-intensity resistance training improves muscle strength, self-reported function, and disability in long-term stroke survivors. Stroke 35 6 (2004) 1404-1409
66. Lum P.S., Burgar C.G., and Shor P.C. Evidence for strength imbalances as a significant contributor to abnormal synergies in hemiparetic subjects. Muscle Nerve 27 2 (2003) 211-221
67. Morrissey M.C., Harman E.A., and Johnson M.J. Resistance training modes: specificity and effectiveness. Med Sci Sports Exerc 27 5 (1995) 648-660
68. Saunders D.H., Greig C.A., Young A., et al. Physical fitness training for stroke patients. Cochrane Database Syst Rev 1 (2004) CD003316
69. Kernan W.N., Inzucchi S.E., Viscoli C.M., et al. Impaired insulin sensitivity among nondiabetic patients with a recent TIA or ischemic stroke. Neurology 60 9 (2003) 1447-1451
70. Ryan A.S., Dobrovolny C.L., Smith G.V., et al. Hemiparetic muscle atrophy and increased intramuscular fat in stroke patients. Arch Phys Med Rehabil 83 12 (2002) 1703-1707
71. Duncan P., Studenski S., Richards L., et al. Randomized clinical trial of therapeutic exercise in subacute stroke. Stroke 34 9 (2003) 2173-2180
72. Chu K.S., Eng J.J., Dawson A.S., et al. Water-based exercise for cardiovascular fitness in people with chronic stroke: a randomized controlled trial. Arch Phys Med Rehabil 85 6 (2004) 870-874
73. Taub E., and Uswatt G. Constraint-induced movement therapy: answers and questions after two decades of research. NeuroRehabilitation 21 2 (2006) 93-95
74. Taub E., Lum P.S., Hardin P., et al. AutoCITE: automated delivery of CI therapy with reduced effort by therapists. Stroke 36 6 (2005) 1301-1304
75. Taub E., Uswatte G., King D.K., et al. A placebo-controlled trial of constraint-induced movement therapy for upper extremity after stroke. Stroke 37 4 (2006) 1045-1049
76. Van Der Lee J.H., Wagenaar R.C., Lankhorst G.J., et al. Forced use of the upper extremity in chronic stroke patients: results from a single-blind randomized clinical trial. Stroke 30 11 (1999) 2369-2375
77. Dromerick A.W., Edwards D.F., and Hahn M. Does the application of constraint-induced movement therapy during acute rehabilitation reduce arm impairment after ischemic stroke?. Stroke 31 12 (2000) 2984-2988
78. Dettmers C., Teske U., Hamzei F., et al. Distributed form of constraint-induced movement therapy improves functional outcome and quality of life after stroke. Arch Phys Med Rehabil 86 2 (2005) 204-209
79. Page S.J., Sisto S.A., Levine P., et al. Modified constraint induced therapy: a randomized feasibility and efficacy study. J Rehabil Res Dev 38 5 (2001) 583-590
80. Page S.J., Sisto S., Levine P., et al. Efficacy of modified constraint-induced movement therapy in chronic stroke: a single-blinded randomized controlled trial. Arch Phys Med Rehabil 85 1 (2004) 14-18
81. Wu C.Y., Chen C.L., Tsai W.C., et al. A randomized controlled trial of modified constraint-induced movement therapy for elderly stroke survivors: changes in motor impairment, daily functioning, and quality of life. Arch Phys Med Rehabil 88 3 (2007) 273-278
82. Grade C., Redford B., Chrostowski J., et al. Methylphenidate in early poststroke recovery: a double-blind, placebo-controlled study. Arch Phys Med Rehabil 79 9 (1998) 1047-1050
83. Conner J.M., Culberson A., Packowski C., et al. Lesions of the basal forebrain cholinergic system impair task acquisition and abolish cortical plasticity associated with motor skill learning. Neuron 38 5 (2003) 819-829
84. Sawaki L., Boroojerdi B., Kaelin-lang A., et al. Cholinergic influences on use-dependent plasticity. J Neurophysiol 87 1 (2002) 166-171
85. Scheidtmann K., Fries W., Müller F., et al. Effect of levodopa in combination with physiotherapy on functional motor recovery after stroke: a prospective, randomised, double-blind study. Lancet 358 9284 (2001) 787-790
86. Sawaki L., Cohen L.G., Classen J., et al. Enhancement of use-dependent plasticity by D-amphetamine. Neurology 59 8 (2002) 1262-1264
87. Dinse H.R., Ragert P., Pleger B., et al. Pharmacological modulation of perceptual learning and associated cortical reorganization. Science 301 5629 (2003) 91-94
88. Loubinoux I., Pariente J., Boulanouar K., et al. A single dose of the serotonin neurotransmission agonist paroxetine enhances motor output: double-blind, placebo-controlled, fMRI study in healthy subjects. Neuroimage 15 1 (2002) 26-36
89. Pariente J., Loubinoux I., Carel C., et al. Fluoxetine modulates motor performance and cerebral activation of patients recovering from stroke. Ann Neurol 50 6 (2001) 718-729
90. Goldstein L. Common drugs may influence motor recovery after stroke. The sygen In acute stroke study investigators. Neurology 45 5 (1995) 865-871
91. Goldstein L. Neurotransmitters and motor activity: effects on functional recovery after brain injury. NeuroRx 3 4 (2006) 451-457
92. Zorowitz R.D., Smout R.J., Gassaway J.A., et al. Neurostimulant medication usage during stroke rehabilitation: the post-stroke rehabilitation outcomes project (PSROP). Top Stroke Rehabil 12 4 (2005) 28-36
93. Cauraugh J.H., and Kim S.B. Stroke motor recovery: active neuromuscular stimulation and repetitive practice schedules. J Neurol Neurosurg Psychiatry 74 11 (2003) 1562-1566
94. Alon G., McBride K., and Ring H. Improving selected hand functions using a noninvasive neuroprosthesis in persons with chronic stroke. J Stroke Cerebrovasc Dis 11 2 (2002) 99-106
95. Woldag H., and Hui-Chan C.W.Y. Modern therapeutic approaches in the rehabilitation of walking ability after stroke response. Stroke 36 5 (2005) 932-933
96. Salter A.C.D., Bagg S.D., Creasy J.L., et al. First clinical experience with BION implants for therapeutic electrical stimulation. Neuromodulation 7 1 (2004) 38-47
97. Jaeger R.J. Lower extremity applications of functional neuromuscular stimulation. Assist Technol 4 1 (1992) 19-30
98. Ward N.S., and Cohen L.G. Mechanisms underlying recovery of motor function after stroke. Arch Neurol 61 12 (2004) 1844-1848
99. Brown J.A., and Pilitsis J.G. Motor cortex stimulation for central and neuropathic facial pain: a prospective study of 10 patients and observations of enhanced sensory and motor function during stimulation. Neurosurgery 56 2 (2005) 290-297 [discussion: 290-7]
100. Forrester L.W., Hanley D.F., and Macko R.F. Effects of treadmill exercise on transcranial magnetic stimulation-induced excitability to quadriceps after stroke. Arch Phys Med Rehabil 87 2 (2006) 229-234
101. Gandiga P.C., Hummel F.C., and Cohen L.G. Transcranial DC stimulation (tDCS): a tool for double-blind sham-controlled clinical studies in brain stimulation. Clin Neurophysiol 117 4 (2006) 845-850
102. Lum P.S., Burgar C.G., Shor P.C., et al. Robot-assisted movement training compared with conventional therapy techniques for the rehabilitation of upper-limb motor function after stroke. Arch Phys Med Rehabil 83 7 (2002) 952-959
103. Masiero S., Celia A., Rosati G., et al. Robotic-assisted rehabilitation of the upper limb after acute stroke. Arch Phys Med Rehabil 88 2 (2007) 142-149
104. Decety J. Can motor imagery be used as a form of therapy?. J NIH Res 7 (1995) 47-48
105. Jack D., Boian R., Merians A.S., et al. Virtual reality-enhanced stroke rehabilitation. IEEE Trans Neural Syst Rehabil Eng 9 3 (2001) 308-318
106. Holden M.K., and Dyar T. Virtual environment training: a new tool for neurorehabilitation. Neurology Report 26 (2002) 62-71
107. Broeren J., Rydmark M., and Sunnerhagen K.S. Virtual reality and haptics as a training device for movement rehabilitation after stroke: a single-case study. Arch Phys Med Rehabil 85 8 (2004) 1247-1250
108. Kjendahl A., Sallstrom S., Osten P.E., et al. A one year follow-up study on the effects of acupuncture in the treatment of stroke patients in the subacute stage: a randomized, controlled study. Clin Rehabil 11 3 (1997) 192-200
109. Wong A.M., Su T.Y., Tang F.T., et al. Clinical trial of electrical acupuncture on hemiplegic stroke patients. Am J Phys Med Rehabil 78 2 (1999) 117-122
110. Nakayama H., Jorgensen H.S., Raaschou H.O., et al. Recovery of upper extremity function in stroke patients: the Copenhagen stroke study. Arch Phys Med Rehabil 75 4 (1994) 394-398
111. Van Buskirk C., and Webster D. Prognostic value of sensory defect in rehabilitation of hemiplegics. Neurology 5 6 (1955) 407-411
112. Bard G., and Hirschberg G.G. Recovery of voluntary motion in upper extremity following hemiplegia. Arch Phys Med Rehabil 46 (1965) 567-572
113. Wade D.T., Langton-Hewer R., Wood V.A., et al. The hemiplegic arm after stroke: measurement and recovery. J Neurol Neurosurg Psychiatry 46 6 (1983) 521-524
114. Jorgensen H.S., Nakayama H., Raaschou H.O., et al. Recovery of walking function in stroke patients: the Copenhagen stroke study. Arch Phys Med Rehabil 76 1 (1995) 27-32
115. Page S.J., Gater D.R., and Bach Y.R.P. Reconsidering the motor recovery plateau in stroke rehabilitation. Arch Phys Med Rehabil 85 8 (2004) 1377-1381
116. Perry J., Garrett M., Gronley J.K., et al. Classification of walking handicap in the stroke population. Stroke 26 6 (1995) 982-989
117. Bohannon R.W. Comfortable and maximum walking speed of adults aged 20-79 years: reference values and determinants. Age Ageing 26 1 (1997) 15-19
118. Lord S.E., McPherson K., McNaughton H.K., et al. Community ambulation after stroke: how important and obtainable is it and what measures appear predictive?. Arch Phys Med Rehabil 85 2 (2004) 234-239
119. Koski L., Mernar T.J., and Dobkin B.H. Immediate and long-term changes in corticomotor output in response to rehabilitation: correlation with functional improvements in chronic stroke. Neurorehabil Neural Repair 18 4 (2004) 230-249
120. Dobkin B.H. Rehabilitation after stroke. N Engl J Med 352 16 (2005) 1677-1684
121. Dobkin B.H., Firestine A., West M., et al. Ankle dorsiflexion as an fMRI paradigm to assay motor control for walking during rehabilitation. Neuroimage 23 1 (2004) 370-381
122. Retchin S.M., Brown R.S., Yeh S.C., et al. Outcomes of stroke patients in Medicare fee for service and managed care. JAMA 278 2 (1997) 119-124
123. Organised inpatient (stroke unit) care for stroke. Cochrane Database Syst Rev 4 (2006)
124. Indredavik B., Bakke F., Solberg R., et al. Benefit of a stroke unit: a randomized controlled trial. Stroke 22 8 (1991) 1026-1031
125. Jorgensen H.S., Kammersgaard L.P., Nakayama H., et al. Treatment and rehabilitation on a stroke unit improves 5-year survival: a community-based study. Stroke 30 5 (1999) 930-933
126. Indredavik B., Slordahl S.A., Bakke F., et al. Stroke unit treatment: long-term effects. Stroke 28 10 (1997) 1861-1866
127. Lincoln N.B., Husbands S., and Trescoli C. Stroke units seem to have a long term impact on patients' outcomes. BMJ 320 (2000) 549
128. Sulter G., Elting J.W., Langedijk M., et al. Admitting acute ischemic stroke patients to a stroke care monitoring unit versus a conventional stroke unit: a randomized pilot study. Stroke 34 1 (2003) 101-104
129. Cavallini A., Micieli G., Marcheselli S., et al. Role of monitoring in management of acute ischemic stroke patients. Stroke 34 11 (2003) 2599-2603
130. Bernhardt J., Dewey H., Thrift A., et al. Inactive and alone: physical activity within the first 14 days of acute stroke unit care. Stroke 35 4 (2004) 1005-1009
131. Lenze E., Munin M., Quear T., et al. Significance of poor patient participation in physical and occupational therapy for functional outcome and length of stay. Arch Phys Med Rehabil 85 10 (2004) 1599-1601
132. Deutsch A., Granger C.V., Heinemann A.W., et al. Poststroke rehabilitation: outcomes and reimbursement of inpatient rehabilitation facilities and subacute rehabilitation programs. Stroke 37 6 (2006) 1477-1482
133. Anderson C., Ni Mhurchu C., Brown P.M., et al. Stroke rehabilitation services to accelerate hospital discharge and provide home-based care: an overview and cost analysis. Pharmacoeconomics 20 8 (2002) 537-552
134. Langhorne P., Taylor G., Murray G., et al. Early supported discharge services for stroke patients: a meta-analysis of individual patients' data. Lancet 365 9458 (2005) 501-506
135. Sonoda S., Saitoh E., Nagai S., et al. Full-time integrated treatment program: a new system for stroke rehabilitation in Japan. Comparison with conventional rehabilitation. Am J Phys Med Rehabil 83 2 (2004) 88-93
136. Legg L. Rehabilitation therapy services for stroke patients living at home: systematic review of randomised trials. Lancet 363 9406 (2004) 352-356
137. Lin J.H., Hsieh C.L., Lo S.K., et al. Preliminary study of the effect of low-intensity home-based physical therapy in chronic stroke patients. Kaohsiung J Med Sci 20 1 (2004) 18-23
138. Page S.J. Intensity versus task-specificity after stroke: how important is intensity?. Am J Phys Med Rehabil 82 9 (2003) 730-732
139. Lincoln N.B., Walker M.F., Dixon A., et al. Evaluation of a multiprofessional community stroke team: a randomized controlled trial. Clin Rehabil 18 1 (2004) 40-47